Glucotrack Unveils Key Innovations at Upcoming Diabetes Conference
Exciting Updates from Glucotrack at the Diabetes Technology Meeting
Glucotrack, Inc. (NASDAQ: GCTK) is gearing up to showcase significant advancements in diabetes technology with updated preclinical data from their continuous blood glucose monitor (CBGM). This presentation will take place during the prestigious 24th Annual Diabetes Technology Meeting, a key event for healthcare professionals focused on innovative solutions for diabetes management.
Details of the Diabetes Technology Meeting
This important meeting is recognized within the medical community as a leading forum for discussions about the latest innovations in diabetes care. It will cover a variety of topics, including cutting-edge automated insulin delivery systems and the latest advancements in continuous glucose monitoring technology.
Overview of Glucotrack's Presentation
Mark Tapsak, PhD, who serves as Vice President of Sensor Technology at Glucotrack, will deliver an oral presentation titled “The Technology Behind Continuous Blood Glucose Monitoring.” He will speak on October 17, emphasizing the impressive capabilities of their CBGM to provide accurate glucose readings in real-time without the drawbacks of traditional monitoring systems.
Innovative Features of the CBGM
Dr. Tapsak expressed enthusiasm about highlighting the updated data which extends previously presented findings. He conveyed that their technology’s unique degree of accuracy allows for seamless diabetes management, enabling a less intrusive approach to everyday life for those living with diabetes.
Poster Presentations to Showcase Research
In addition to the oral presentation, Glucotrack will also present two informative posters at the meeting. These contributions are expected to provide insights into the ongoing research and innovation associated with continuous blood glucose monitoring systems.
Details of the Posters
Poster #1: In Vivo Evaluation of Novel Long-Term Intravascular Continuous Blood Glucose Monitor in a Chronic Ovine Model.
Poster #2: Exploratory Study of Continuous Glucose Monitoring in the Epidural Space in Swine.
Viewing the Posters
The poster sessions are scheduled for Tuesday, October 15 from 4:30 PM to 6:30 PM and Wednesday, October 16 from 5:00 PM to 7:00 PM. Information regarding the posters will be made available on the Glucotrack website following the sessions.
About Glucotrack, Inc.
Glucotrack, Inc. is dedicated to revolutionizing diabetes management through innovative technology. Their continuous blood glucose monitoring system is uniquely designed for long-term use, with remarkable sensor longevity of three years and minimal calibration required, eliminating the need for any on-body wearable components.
Contact Information
To learn more about Glucotrack’s offerings, interested parties can refer to glucotrack.com. For inquiries, Glucotrack provides direct contact channels:
Investor Relations:
investors@glucotrack.com
Media Inquiries:
GlucotrackPR@icrinc.com
Frequently Asked Questions
What is Glucotrack showcasing at the upcoming meeting?
Glucotrack will present updated preclinical data for its continuous blood glucose monitoring system during the Diabetes Technology Meeting.
Who is presenting at the conference?
Dr. Mark Tapsak, the Vice President of Sensor Technology at Glucotrack, will provide an oral presentation on the technology behind their CBGM.
What are the sessions' dates for the poster presentations?
The poster sessions are scheduled for October 15 and 16, 2024, with two different time slots each day.
What are the titles of the posters being presented?
The titles are “In Vivo Evaluation of Novel Long-Term Intravascular Continuous Blood Glucose Monitor in a Chronic Ovine Model” and “Exploratory Study of Continuous Glucose Monitoring in the Epidural Space in Swine.”
How long does Glucotrack’s monitoring system last?
Glucotrack’s continuous blood glucose monitoring system is designed to last for three years with minimal calibration.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.